Beijing Volt Technology Co., Ltd
--Specialized manufacturer of high quality precision filtration infusion set
"Pursuing precision filtration to meet the needs of doctors and patients" is the corporate purpose of Beijing Volt, The pursuit of precision filtration to meet the needs of doctors and patients" is the corporate purpose, lofty ideals and glorious mission of Beijing Volt Company, and is also the source of vitality and inexhaustible power for Volt people to continue to innovate with passion.
Beijing Volt Technology Co., Ltd. is a high-tech enterprise specializing in the research, development and production of high-precision medical precision filters, precision filtration and infusion device series products, and medical equipment products, with the core technology - nuclear pore membrane separation technology, and the results of the nuclear tracing technology into the field of medical devices. The main products are GLQ series precision filters, SYQ series precision filtration infusion devices and so on. It has created a new industry of precision filter infusion device and established a new concept of clinical safety infusion.
Beijing Volt Technology Co., Ltd. precision filtration series products manufacturing technology has been among the world's advanced ranks, the company has 12 national patents (see "product patents" column), has participated in and responsible for the drafting of the GB 18458.1, GB18458.3, YY We have participated in and been responsible for drafting GB 18458.1, GB18458.3, YY 0321.1, YY 0321.3, etc. In 2004, our quality management has passed ISO 9001:2000 and ISO 13485:2003 quality system certification.
Volt products are widely used in infusion, anesthesia, blood transfusion, cell separation and other fields. The company produces five series of more than 100 specifications of sterile medical equipment products, with high filtration precision, clinical relevance, full range of specifications, easy to use and so on, the products in the use of the process of the majority of medical staff, medical experts and clinical patients praise.
Since the establishment of the company in 1997, while maintaining high growth, Beijing Volt has taken the responsibility to improve the domestic medical device technology level, focusing on investment in technology and research and development, the company has two production plants in Beijing, occupying a total area of 40,000 square meters, of which 20,000 square meters of the production building area, with large-scale production of a series of precision filters and infusion devices. The company has two production plants in Beijing, covering a total area of 40,000 square meters, including a production building area of 20,000 square meters, with the ability to produce a series of precision filters and infusion devices on a large scale.
Beijing Volt has formed a unique sales network and service network centered in Beijing and established in the whole country, and its products are sold to 24 provinces, cities and autonomous regions in China.
Adhering to the concept of "Focus, Specialization, Innovation", the company will continue to develop new functional products to meet clinical needs and lead the development of the industry, and make unremitting efforts to promote the overall development of the national medical device industry and make contributions. Comparison of the adverse reactions between the Salkin group and the control group is shown in the table below. Comparison of adverse reactions between Salkin group and control group Group Number of cases Vascular reactions Skin local reactions Systemic reactions Salkin group 100 2 1 0 Control group 100 14 9 6 X2 value 8.690 4.669 6.897 P value 0.003 0.035 0.008